• Galderma receives FDA Complete Response Letter with comments isolated to Chemistry, Manufacturing, and Controls items
• International Chamber of Commerce (ICC) arbitration is complete and the regulatory applications are under review
• Regulatory filings in other territories are ongoing and remain on track

&

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

ALASTIN adds to its solution serums with a radically new form of Vitamin C for skin that looks smoother and more radiant.

• Galderma officially opens its U.S.

First and Only Hyaluronic Acid Dermal Filler for Cheeks with Cannula¹ Now Offers Aesthetic Professionals New Delivery Method of Injectable Treatment